Skip to main content

Advertisement

Table 1 Demographics of total patient population

From: Persistence rates and medical costs of biological therapies for psoriasis treatment in Japan: a real-world data study using a claims database

  Total BT-naïve BT-experienced
ADL IFX SCK UST Sub total ADL IFX SCK UST Sub total ADL IFX SCK UST Sub total
Number of patients 42 52 21 90 205 37 48 13 79 177 5 4 8 11 28
Average Age 50.0 46.2 45.4 46.8 47.1 50.9 46.0 46.2 46.5 47.3 43.4 47.5 44.3 48.4 46.2
% Female 7.1% 21.2% 33.3% 17.8% 18.1% 8.1% 20.8% 46.2% 20.3% 19.8% 0.0% 25.0% 12.5% 0.0% 7.1%
  1. ADL Adalimumab, IFX Infliximab, SCK Secukinumab, UST Ustekinumab